FDA Investigator Armando Chavez, MS

Armando Chavez, MS has conducted inspections on 168 sites in 1 countries as of 28 Aug 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
168
Last Inspection Date:
28 Aug 2013
Investigator Role:
FDA Investigator
Redica ID:
100007889
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Armando Chavez, MS:
Abby Lmozeke Baker, Alexander M Kay, Allen F Hall, Amy A Johnson, Amy C Amaro, Ana Djurdjevic, Angela Shepas, Anthony N Onianwa, Barbara D Wright, Bruce W Benware, Bryce A May, Carla M Fernandez Borges, Charles D Boison, Charles L Larson, Chelsea N Sealey, Cheryl D Mccall, Christopher M Jenner, Cody D Rickman, Comyar Shoghi, Dana M Klimavicz, Daniel J Lahar, Darla J Christopher, Darren S Brown, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Dolores Harper, Emily S Mcgann, Gabriel M Guevarra, Garrad R Poole, Gene D Arcy, Gloria A Milster, Irina Gaberman, Jacob W Reynolds, James D Hildreth, Janet Pulver, Jeffery A Johnson, Joel D Hustedt, Joey V Quitania, John A Daubenspeck, Joseph M Allen, Jude C Dikes, Julian C Hanson, Ka L Wong, Karen J Bak, Katlin N Stubbs, Kenneth S Boehnen, Kham Phommachanh, Kimberly M Lichter, Lakecha N Lewis, Laurissa S Flowers, Lawrence H Howell, Linda Thai, Louis B Cencetti, Mark C Saale, Mary Ewilkerson Brinsko, Matthew J Gretkierewicz, Melissa D Kalik, Michael N Roberts, Michelle J Hines, Mizanne E Lewis, Natalie J Ayoub, Paquita F Segarra, Patricia M Jacobs, Paul R Whitby, Randall N Johnson, Richmond K Yip, Robert S Sweeton, Ronda Rloyd Jones, Sandra L Shire, DMD, MPA, Sandra Sejdinovic, Sara Jdent Acosta, Shaquenta Y Perkins, Sherri J Jackson, Sherri N Rohlf, MD, Sunitha K Rajaram, PhD, Tamal K Chakraborti, PhD, Tammy Battisti, Tania Y Hall, Thomas R Beilke, Timothy P Lafave, Timothy T Kapsala, Tonia L Sawyer, Traci M Armand, Travis R Hunt, Valerie L Whipp, Vanessa R Muller, Vien Q Le, William J Leonard, Yvette E Guillermo, Yvonne C Wilkes, Zachary A Bogorad

Armando Chavez, MS's Documents

Publish Date Document Type Title
April, 2001 FDA 483 Gleason, Donald - Form 483, 2001-04-02
February, 2002 EIR Zimbroff, Daniel M.D - EIR, 2002-02-14
March, 2004 EIR Joseph S. Gimbel, MD - EIR, 2004-03-05
February, 2001 EIR Dennis C Westin MD - EIR, 2001-02-06
December, 2006 FDA 483 Shapiro, William R. M.D - Form 483, 2006-12-06
December, 2000 EIR Dr. Jeffrey Morris, M.D. - EIR, 2000-12-06
July, 2000 EIR Grossman, Jay (m.d.) - EIR, 2000-07-10
April, 2000 EIR Rosenthal, Murray H., D.O. - EIR, 2000-04-28
May, 2000 EIR Kiersch, Theodore A. Dr. - EIR, 2000-05-23
March, 2010 EIR Terry O'reilly, M.D. - EIR, 2010-03-26
October, 2000 FDA 483 University of Arizona Human Subject Committee - Form 483, 2000-10-06
October, 2000 EIR University of Arizona Human Subject Committee - EIR, 2000-10-06
March, 2004 FDA 483 Joseph S. Gimbel, MD - Form 483, 2004-03-05
September, 2002 FDA 483 LaMear, William R MD - Form 483, 2002-09-03
August, 2000 FDA 483 Mclinn, Samuel E - Form 483, 2000-08-02
November, 2001 EIR Jeanette Wendt MD - EIR, 2001-10-30
October, 2004 EIR Gotfried, Mark H MD - EIR, 2004-10-05
August, 2000 EIR Mclinn, Samuel E - EIR, 2000-08-02
May, 2001 FDA 483 Garewal, Harinder MD - Form 483, 2001-05-11
April, 2001 EIR Gleason, Donald - EIR, 2001-04-02
November, 2001 EIR Jeanette Wendt MD - EIR, 2001-10-31
April, 2000 FDA 483 Rosenthal, Murray H., D.O. - Form 483, 2000-04-28
September, 2002 EIR LaMear, William R MD - EIR, 2002-09-03
November, 2001 FDA 483 Jeanette Wendt MD - Form 483, 2001-11-09
May, 2001 EIR Garewal, Harinder MD - EIR, 2001-05-11
February, 2002 EIR Zimbroff, Dan L Md - EIR, 2002-02-14
October, 2000 EIR Mohammed A. Bari, MD - EIR, 2000-10-27
November, 2001 EIR Jeanette Wendt MD - EIR, 2001-11-09
November, 2003 EIR Dr. Gerald Wolfley, M.D. - EIR, 2003-11-13
October, 2002 EIR Mollen, Martin D., MD - EIR, 2002-10-29
February, 2001 FDA 483 Dennis C Westin MD - Form 483, 2001-02-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more